Discover how a scalable rAAV9 production process delivered consistent growth, viability, and titers from microbioreactors to 200 L bioreactors. This application note highlights robust scale-up performance, reduced host cell DNA, and a streamlined approach to producing high-quality viral vectors from process development through manufacturing.
Learn more